Premium
Clinical trials as a path toward equity
Author(s) -
Benson Al B.,
Carlos Ruth C.
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33648
Subject(s) - medicine , colorectal cancer , clinical trial , equity (law) , oncology , population , family medicine , cancer , environmental health , political science , law
Results from a secondary analysis of the first‐line metastatic colorectal cancer trial CALGB/SWOG 80405 demonstrate the potential for participation in a clinical trial to provide a level of equity which thus far has remained elusive for the overall population of Black patients with colorectal cancer. Although encouraging, what is lacking in trial design is the inclusion of factors beyond standard efficacy, safety, and patient‐reported outcomes that address social determinants of health that clearly are not only detriments to trial enrollment but also can have profound consequences in outcomes, including survival.